Literature DB >> 31700883

Increased cancer-specific mortality of very small size in carcinoembryonic antigen-elevated rectal cancer.

Haiqiang Pan1, Junhui Cui1, Ke Cai1, Yena Zhou2.   

Abstract

BACKGROUND: The present study aimed to investigate the cause-specific survival (CSS) of very small rectal cancer in the context of preoperative serum carcinoembryonic antigen (CEA) elevation.
METHODS: Patients diagnosed with node-negative rectal cancer from the Surveillance, Epidemiology, and End Results (SEER) database from January 2004 to December 2010 meeting the inclusion criteria were identified for this study. The Cox proportional hazards regression analyses were conducted to identify independent factors associated with CSS. Pearson's chi-squared tests and Kaplan-Meier methods were performed.
RESULTS: A total of 8,413 patients were included into our study. Kaplan-Meier analyses showed lower 7-year CSS rate of very small tumors (≤5 mm) compared to those larger than 40 mm (70.4% vs. 76.0%, log-rank P=0.469). Multivariate Cox analyses showed that patients with very small tumor size (≤5 mm) was also associated with a significantly increased risk of cancer-specific mortality compared with those with large tumor size (HR =2.567, 95% CI: 1.285 to 5.130, P=0.008, using ≥41 mm, C+ as a reference).
CONCLUSIONS: Very small tumor size in the context of preoperative serum CEA elevation could be a surrogate for biological aggressiveness. Our finding would provide a better understanding of tumor biology for us and elicit more future biological researches. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Tumor size; carcinoembryonic antigen (CEA); rectal cancer

Year:  2019        PMID: 31700883      PMCID: PMC6803206          DOI: 10.21037/atm.2019.08.81

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  29 in total

Review 1.  American Joint Committee on Cancer prognostic factors consensus conference.

Authors:  J W Yarbro; D L Page; L P Fielding; E E Partridge; G P Murphy
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

3.  ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

Authors:  Gershon Y Locker; Stanley Hamilton; Jules Harris; John M Jessup; Nancy Kemeny; John S Macdonald; Mark R Somerfield; Daniel F Hayes; Robert C Bast
Journal:  J Clin Oncol       Date:  2006-10-23       Impact factor: 44.544

4.  Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients.

Authors:  J M Jessup; R Giavazzi; D Campbell; K Cleary; K Morikawa; I J Fidler
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

5.  Prognostic impact of tumour size in completely resected thymic epithelial tumours.

Authors:  Takayuki Fukui; Koichi Fukumoto; Toshiki Okasaka; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Akihiro Hirakawa; Hisashi Tateyama; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2016-12       Impact factor: 4.191

6.  Percentage of tumor in prostatectomy specimens: a study of American Veterans.

Authors:  Robin T Vollmer
Journal:  Am J Clin Pathol       Date:  2009-01       Impact factor: 2.493

7.  Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.

Authors:  Yan Shibing; Liu Liangren; Wei Qiang; Liao Hong; Song Turun; Lei Junhao; Yang Lu; Yuan Zhengyong; Jiang Yonghao; Fu Guangqing; Li Yunxiang; Cao Dehong
Journal:  BJU Int       Date:  2016-03-27       Impact factor: 5.588

Review 8.  Metastasis: an early event in cancer progression.

Authors:  Yijun Hu; Xiya Yu; Guixia Xu; Shanrong Liu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-29       Impact factor: 4.553

Review 9.  Parallel progression of primary tumours and metastases.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2009-04       Impact factor: 60.716

10.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Authors:  Paul Lochhead; Aya Kuchiba; Yu Imamura; Xiaoyun Liao; Mai Yamauchi; Reiko Nishihara; Zhi Rong Qian; Teppei Morikawa; Jeanne Shen; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

View more
  1 in total

1.  Tumor Deposits and Perineural Invasion had Comparable Impacts on the Survival of Patients With Non-metastatic Colorectal Adenocarcinoma: A Population-Based Propensity Score Matching and Competing Risk Analysis.

Authors:  Bin Luo; Xianzhe Chen; Guanfu Cai; Weixian Hu; Yong Li; Junjiang Wang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.